SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040121
Filing Date
2023-11-09
Accepted
2023-11-09 17:19:59
Documents
76
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1826971
2 ex10-3.htm EX-10.3 165899
3 ex31-1.htm EX-31.1 18115
4 ex31-2.htm EX-31.2 18093
5 ex32-1.htm EX-32.1 9074
  Complete submission text file 0001493152-23-040121.txt   9979109

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocx-20230930.xsd EX-101.SCH 69457
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocx-20230930_cal.xml EX-101.CAL 75309
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocx-20230930_def.xml EX-101.DEF 362262
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocx-20230930_lab.xml EX-101.LAB 568613
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocx-20230930_pre.xml EX-101.PRE 472171
70 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1831385
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 231393813
SIC: 2835 In Vitro & In Vivo Diagnostic Substances